Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma: A Step Closer to Clinical Translation?

Affiliations

¹ Department of Urology, University Hospital Basel, University of Basel, Switzerland. Electronic address: crentsch@uhbs.ch.
² Department of Urology, University Hospital Basel, University of Basel, Switzerland; Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.
³ Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.

Editorial

Cyrill A Rentsch et al. Eur Urol. 2017 Dec.

. 2017 Dec;72(6):960-961.

doi: 10.1016/j.eururo.2017.06.022. Epub 2017 Jul 5.

¹ Department of Urology, University Hospital Basel, University of Basel, Switzerland. Electronic address: crentsch@uhbs.ch.
² Department of Urology, University Hospital Basel, University of Basel, Switzerland; Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.
³ Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.

No abstract available

Comment on

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.
Pietzak EJ, Bagrodia A, Cha EK, Drill EN, Iyer G, Isharwal S, Ostrovnaya I, Baez P, Li Q, Berger MF, Zehir A, Schultz N, Rosenberg JE, Bajorin DF, Dalbagni G, Al-Ahmadie H, Solit DB, Bochner BH. Pietzak EJ, et al. Eur Urol. 2017 Dec;72(6):952-959. doi: 10.1016/j.eururo.2017.05.032. Epub 2017 Jun 3. Eur Urol. 2017. PMID: 28583311 Free PMC article.